01 C & D Latar Belakang GPP.ppt

8/18/2019 01 C & D Latar Belakang GPP.ppt

1/38

PROGRAM STUDI PROFESI APOTEKER

FAKULTAS FARMASI

UNIVERSITAS PADJADJARAN

TAHUN AKADEMIK 2013/2014

By : Dra A!"ar#$%&ar' MM( A)*


2/38

Da*a )r'"a&' :Na!a : A!"ar#$%&ar'

T+!)a* , T-.La'r: Ba%&$%-(20 Mar+* S*a*$# : '#*r' &ar'

Dr#Ba!"a%-

S$-ya%*(A)* &a% '"$&ar' Sa#*' R'5a%' 617728&a% R+-' D9' S+)*'617738

N%*a : 0;734;;


3/38

RI


4/38

Topik/Pokok bahasan

Pendahuluan Praktek Kefarmasian:

1.DEVELOPING PHARA!" PRA!#I!E !OPO$NDER % DI&PEN&ER DR$G #HERAP" ANAGER

Paradi'ma (aru tentan' )raktek kefarmasian

i.Latar (elakan' ii.Paradi'ma sehat iii.Dimensi (aru dari )raktek kefarmasian*)r+fesi

i,.A)+teker s(' -health are team/ ,.K+mitmen atas )eru(ahan

0.A Pratial 'iude t+ Pharmaeutial are i.Pratise &kills ii.Pr+fesisi+nal Pratise De,el+)ment

iii.Pratise &ite De,el+)ment i,.&tandar Pelaanan Kefarmasian di A)+tek

2.G++d Dis)ensin' Pratise3.Inter)ers+nal skill +mmuniati+n4.Diskusi kel+m)+k


5/38

COMPOUNDING IS THE PRACTICE OF

PREPARING DRUGS IN NEW FORMS.

e.g :

1.DRUG MANUFACTURERONLY PROVIDES TABLET,

A “COMPOUNDING

PHARMACIST” MIGHT

MAKE A MEDICATED

PULVIS THAT CONTAINS

THE DRUGS.

PEOPLE WHO HAVE

DIFFICULTY SWALLOWING

THE TABLET MAY PREFER

THE PULVIS


6/38

.MI!ING

DIFFERENTSTRENGTH

"g,#g,#$g% OF

CAPSULES OR

TABLET TO YIELD

DESIRED AMOUNT

OF MEDICATIONINDICATED BY

THE DOCTOR

THE FORM OF COMPOUNDING IS FOUND ATCOMMUNITY OR HOSPITAL PHARMACIES OR INHOME

ADMINISTRATION THERAPY.


7/38

DISPENSIN3 OBAT =DISPENSING BERASAL DARI

KATA BAHASA INGGRIS( ya'*$

TO DISPENSE =ANG SE>ARA

HARAFIAH BERARTIMEMBAGIKAN/

MEN=ERAHKAN

APABILA DOKTER DISPENSINGOBAT ARTIN=A DOKTERMEMBAGIKAN/MENERAHKAN

OBAT KEPADA PASIEN

KEN=ATAANN=A DOKTER

TIDAK HAN=A MEMBAGIKAN

OBAT( JUGA MEN=IMPANSEJUMLAH OBAT DI TEMPATPRAKTEK PRIBADIN=A


8/38

SEPARATION OF PRESCRIBING FROM

DISPENSING

PHARMACIST ARE REGULATED SEPARATELY FROM PHYSCIANS:SUCH AS “DISPENSING PHYCSIANS “ :THE AMA " American Medical Association% CODE ETHICS :

PHYCSIANS MAY DISPENSE DRUGS WITHIN THEIR OFFICE

PRACTICES AS LONG AS THERE IS NO PATIENT E!PLOITATION

AND PATIENT HAVE THE RIGHT THAT WRITTEN PRESCRIPTION CAN BE FILLED ELSEWHERE. ASIAN COUNTRIES SUCH AS CHINA,MALAYSIA AND S&PORE :

DOCTORS ARE ALLOWED TO DISPENSE DRUGS THEMSELVES

AND THE PRACTICE OF PHARMACY IS SOMETIMES

INTEGRATED WITH THAT OF PHYCSIANS, PARTICULARLY IN

TRADITIONAL CHINESE MEDICINE.CANADA :

IT IS COMMON FOR MEDICAL CLINIC AND A PHARMACY TO BE

LOCATED TOGETHER AND FOR THE OWNWERSHIP IN BOTH

ENTERPRISES TO BE COMMON ,BUT LICENSED SEPARATELY


9/38'''.()e#eg*++e-.$#


10/38

P**/0g#* *2

NEW PARADIGM FOR PHARMACY PRACTICE


11/38

1D+?+.)'%- Par!a@yPra@*'@+PARADIGMA BARU TENTANG PRAKTEK

KEFARMASIAN

COMPOUNDER *3/ DISPENSER DRUG

THERAPY MANAGER

C#423/e D054e35e


12/38

A#o*e0er se$.$-A#o*e0er se$.$- *-, 0ese$*$% (e$/* 4$re *e$,) +$%*-, 0ese$*$% (e$/* 4$re *e$,) +$%

#e%;$,7%. 0ese%$%.$% 0o,7%-0$s- $%*$r$ #$s-e%#e%;$,7%. 0ese%$%.$% 0o,7%-0$s- $%*$r$ #$s-e%

+e%.$% +o0*er+e%.$% +o0*er +$/$, s$s$r$% #e%.o$*$% #$s-e% (.$#+$/$, s$s$r$% #e%.o$*$% #$s-e% (.$#

>//er)>//er)


13/38

1Pra*' +ar!a#'a% y- !+.')$*' )+!"$a*a%*!#

)+%-+%&a.'a% mutu #+&'aa% ar!a#'(

)+%-a!a%a%()+%-a&aa%( )+%y'!)a%a% &a% )+%&'#*r'"$#'a%

a*a$

)+%ya.$ra% "a* ()+%-+..aa% "a*()+.aya%a%

"a* a*a#

r+#+) &*+r()+.aya%a% '%r!a#' "a*(#+r*a

)+%-+!"a%-a% "a*("aa% "a* &a% "a*

*ra&'#'%a.

LANDASAN HUKUM :


14/38

S2*(2 *)*3 *(*2 4*/2*3 *)*36*)*3 -*3g

/0#*752/7*3 23(27 /0g23*7*3 /*+*#

#e3e(*47*3

diagnosa,mencegah,meng!ang"an,

menghi#ang"an,men$em%h"an &en$a"i' a'a

ge(a#a &en$a"i',#"a a'a "e#ainan %adaniah

dan !ohaniah &ada mansia a'a he)an dann'" mem&e!e#o" a'a mem&e!indah %adan

a'a %agian %adan mansia*

"Ke4.Me3Ke5 3.189K*9B VII9()3 1;1%

OBAT HARUS DIPERGUNAKAN5e*g*0#*3* #e5(03-* 7*e3* /*4*(

#e30#2+7*3 e


15/38

PHARMACIST ARE E!PECTED TO BECOME MORE INTEGRAL WITHIN

HEALTH CARE SYSTEM

NOT +UST

DISPENSING

MEDICATION,UT

PHARMACIST

-ILL E PAID FORTHEIR PATIENT

CARE S.ILLS

DRU3T?ERAP@ MANA3ER

A54e7 Leg*+ /0 INDONESIA : PP 819== ((g Pe7e>**3 Ke


16/38

MEDI>ATION THERAP=MANAGEMENT 6MTM8:

PELA=ANAN KLINIS6FARMASI KLINIS8=GDIBERIKAN OLEHSEORANG APOTEKER

MISAL :

1ANALISA PENGOBATAN BAIK RESEP MAUPUN NON RESEP

DAN HERBAL =ANG DIBUTUHKAN PASIEN2REKONSILIASI PENGOBATAN PASIEN DAN EDUKASI

UNTUK MENINGKATKAN KUALITAS HIDUP PASIEN DAN

MENURUNKAN BIA=A KESEHATAN


17/38

J7,/$ o$* +$% #ro,os- s$%.$* $0*-


18/38

"$* -s e$/*=

"?O 19'6:

Ge$/* -s $ s*$*e o< 4o,#/e*e#;s-4$/,e%*$/ $%+ so4-$/ He//e-%.%o* ,ere/; *e $se%4e or+ese$se or -%>r,-*;

"?O 198':

G?e$/* -s *e e&*e%* *o H-4-%+--+7$/ or .ro7# -s $/eo% *e$%+*o re$/-se $s#-r$*-o%s $%+s$*-s


19/38

PERUBAHAN PARADIGMA SEHAT

PreventingDisease

TreatingDisease

ManagingHealth

ManagingDisease

PreventingDisease

TreatingDisease

ManagingHealth

ManagingDisease

Konsep BisinisKAEF saat ini

Konsep BisinisKAEF ke depan

Wellness

Illness

ChronicAcute

Illness

Wellness

Acute Chronic

Individual

K%#+) B'#%'#Far!a#' Saa* '%'

K%#+) B'#%'#Far!a#' +

D+)a%


20/38

[5-GPs Principles in Quality Assurance of Pharmaceutical

Products]

2 b

a s i c

g o a l s

GMP

Good Manufacturing

Practices

GPP

Good Pharmacy

Practices

GDP

Good Distributi on

Practices

GP

Good toragePractices

G!P

Good !aborator y

Practices

Quality Assurance of Pharmaceutical Products

3PP!#

Good Prescribing Practices

3PP!$

Good Clinical Practices

Quality Assurance of

Clinical Therapy

3P Good Pharmacovigilance

Practices

"#"A! Q$A!%"& MA'AG(M('" %'P)A*MA+($"%+A! %'D$"*&


21/38

Sa' Pedoman $ang di&a"ai n'"

men(amin %ah)a #a$anan $ang di%e!i"an/a!masis "e&ada se'ia& &asien 'e#ah

memenhi .a#i'as $ang 'e&a' dan 'e!(amin

Di&e!#"an sa' s'anda! nasiona#

'e!"ai' dgn &!oses &e#a"sanaann$a

se!'a /asi#i'as $g di&e!#"an,

Pedoman GPP di%a' %e!dasa!"an #a$anan "e/a!masian

$ang di%e!i"an O#eh Fa!masis

Da&a' Di"a'a"an %ah)a GPP me!&a"an ca!a n'"

mene!a&"an #a$anan "e/a!masian (Pharmaceu!ca" Care#


22/38

Pharmaceutical +arePractice SOP

Patient

Q$ A!%" &

#f

!%,(

%dentifying*esol.ing

Pre.entingD*P - M(

S7s*$%s- U*$,$ 3PP

APOTEKER


23/38

3PP $*$7 Te 3oo+P$r,$4; Pr$4*-4e$+$/$ s*$%+$r+ +$r-

07$/-*$s #e/$;$%$%


24/38

Pharmaceutical CareIs a Practice

Patient focused

I%*+ra#' .a%-#$%- &+%-a% )a#'+%

T+ra)' "a* ra#'%a.: *+)a*( ++*'( a!a%(%ya!a%( "'aya

Quality of life

Denite outcome T+r&$!+%*a#'

DRP (Drug Related Problem)


25/38

PARADI3MA TERKINIPELA@ANAN KEFARMASIAN

Drug orientedPatient Oriented

(Good Pharmacy Practice wPharmaceutical Care )


26/38

1. Sebagai pedoman praktek apoteker

dalam menjalankan profesi.

2. Untuk melindungi masyarakat dari

pelayanan yang tidakprofesional, medication errors

3. Melindungi profesi dalam

menjalankan praktek kefarmasian.


27/38

KompetensiTinggi KualitasSDM

Standar

Pelayanan

Komitmen,Kontribusi, Konsistensi Kepuasan,Jaminan,efisien,efektif

Perusahaan yg tumbuh

berkesinambungan

Standar

ApotekGPP Pharm Care


28/38

S*$%+$r #e/$;$%$% Ke


29/38

!1!1!PELA@ANAN!1!1!PELA@ANAN

RESEPRESEP/0101010srining resep3yarat administratif 4esesuaian farmaseti Pertimbangan linis3alergi0( dan interasi

obat0

/0101020Penyiapan obat310Peracian +#MP#$'D%'G

20(tiet

/04emasan obat 60Penyerahan obat G##D D%P('%'G P*A+"%+(50%nformasi obat 704onseling

80Monitoring penggunaan obat


30/38

rining *esep !dministrati"e #rrors

Pharmaceutical #rror

Clinical #rror

D!$%!R P&'%!!

*ritish +ational $ormulary (*+$)

Drug Information ,andboo-

!,$'

DRUG RELATED

PROBLEM


31/38

Pa%!i"

Pen$ia&an

O%a' 0Com&onding1

Dis'!i%si Pen$im&anan

di A&o'i"

Pen$im&anan

di gdang

Pemesanan

a&o'i"

Pene!imaan

Pene!imaan!ese&

Pen#isan

!ese&

Pemanggi#an &asienPen$e!ahan o%a'

0Dis&ensing

Pemahaman .e'aa'an

RANTAI PELAYANAN OAT

S'a's 2da'a &asien

Sc!eening

!ese&

E'i"e'

HK 2002

In/o!masi3Conse#ing

MEDICATION ERROR

COUNSELING

Ke(e*3g*3

S$ee303g e5e4 :

A/#0305(*50 e

P)*#*$e2(0$*+

e

C+030$*+ e O2($#eM30(03g

I/e3(0


32/38

Retail Pharmacy


33/38


34/38

Far!a#'# )$%ya )+ra% ya%-)+%*'%- ar+%a ar!a#'#

&+%-a%)+%-+*a$a%(+a.'a% &a%)+r'.a$ ya%- *+r'%*+-ra#'

a%*ara )+%-+*a$a%+ar!a#'a% *ra&'#'%a. &-%

a#)+ '%' )a#'+%(&'#+r*a')+%-+..aa% &a% +!a!)$a%"+r!$%'a#'(a*'

"+r.a"ra#' &-% *+%a-a+#+a*a% .a'%%ya $%*$!+!"+r'a% #.$#' *&)

!a#a.a+*+ra'*a%

"a* 6DRP8

C?e$/* 4$re

*e$, *++:P$s-e% +$%

se/7r7 *e%$.$#ro


35/38

1.Ke0>*7*3 /*0 #*503g 3eg** (e)*/*4 “g/ 4*$(05e

g20/e+03e5” ()/4 P*7(e7 4


36/38

SK MENKES %102/MENKES/SK/I/2004 **-S*a%&ar P+.aya%a% K+ar!a#'a% &' A)*+

PP 1/2007 **- P++r5aa% K+ar!a#'a%

UU K+#+a*a% %3;/2007


37/38


38/38

Documents

01 C & D Latar Belakang GPP.ppt